headline
space
headcopy
Reinventing Therapeutics Through Chemical Genomics
LINE
top >  Company >  Investors

Investors

The company has raised a total of $9M in three rounds of funding in April, 2002,
April, 2003 and July, 2004. Aphoenix's Investors are as follows:

space - Nomura Research & Advisory
- JAFCO
- SBI TransScience
- Bio-sight Capital